Mobile

A Study to Estimate the Immune Response Following a Challenge Dose in Adults (≥ 50 years old) Vaccinated With a Primary Series of an Hepatitis B Vaccine

Update Il y a 4 ans
Reference: EUCTR2009-016721-33

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To describe the Seroprotection rate (SPR) at least 2 years following completion of a primary series of modified process RECOMBIVAX HB™ ( HBVaxPRO) and 1 month following a challenge dose of modified process RECOMBIVAX HB™ To describe the Seroprotection rate (SPR) at least 2 years following completion of a primary series of ENGERIX-B™ and 1 month following a challenge dose of modified process RECOMBIVAX HB™.

Inclusion criteria

  • Healthy subjects, active immunisation against Hepatitis B

Links